I’m satisfied with the regulatory environment and how it leads to the handling of my genetic data. There are no negative consequences for me sharing my data with regards to employment or health insurance [1] [2]. If pharma companies are creating useful pharma products from this aggregated data, that is the goal. If those products are too expensive, that is a healthcare policy issue. If you’re unhappy, call a Congressional rep.

[1] https://www.eeoc.gov/statutes/genetic-information-nondiscrim...

[2] https://www.genome.gov/about-genomics/policy-issues/Genetic-...